Evotec SE (EVO)
1.54
-0.03
(-1.91%)
USD |
NASDAQ |
Oct 09, 16:00
1.54
0.00 (0.00%)
After-Hours: 16:09
Evotec EPS Diluted (Quarterly) : -0.1526 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1526 |
| March 31, 2026 | -0.4017 |
| December 31, 2025 | 0.0479 |
| September 30, 2025 | -0.1417 |
| June 30, 2025 | -0.1387 |
| March 31, 2025 | -0.0936 |
| December 31, 2024 | -0.1227 |
| September 30, 2024 | -0.1228 |
| June 30, 2024 | -0.2882 |
| March 31, 2024 | -0.0633 |
| December 31, 2023 | -0.049 |
| September 30, 2023 | -0.1197 |
| June 30, 2023 | -0.0459 |
| March 31, 2023 | -0.0421 |
| December 31, 2022 | -0.0785 |
| September 30, 2022 | -0.1347 |
| June 30, 2022 | -0.0841 |
| March 31, 2022 | -0.2325 |
| December 31, 2021 | -0.102 |
| September 30, 2021 | 0.481 |
| June 30, 2021 | 0.2202 |
| March 31, 2021 | 0.1934 |
| December 31, 2020 | 0.001 |
| September 30, 2020 | -0.0055 |
| June 30, 2020 | -0.0358 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0623 |
| December 31, 2019 | 0.0291 |
| September 30, 2019 | 0.0707 |
| June 30, 2019 | -0.009 |
| March 31, 2019 | 0.0497 |
| December 31, 2018 | 0.1207 |
| September 30, 2018 | 0.1363 |
| June 30, 2018 | 0.0595 |
| March 31, 2018 | 0.0144 |
| December 31, 2017 | 0.0421 |
| September 30, 2017 | 0.0095 |
| June 30, 2017 | 0.011 |
| March 31, 2017 | 0.0266 |
| December 31, 2016 | 0.0593 |
| September 30, 2016 | 0.0392 |
| June 30, 2016 | 0.0168 |
| March 31, 2016 | -0.0055 |
| December 31, 2015 | 0.0219 |
| September 30, 2015 | -0.0111 |
| June 30, 2015 | 0.0611 |
| March 31, 2015 | -0.0055 |
| December 31, 2014 | 0.0062 |
| September 30, 2014 | -0.0196 |
| June 30, 2014 | -0.0022 |
| March 31, 2014 | -0.0205 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | -0.1897 |
| Codexis, Inc. | -0.1318 |
| Lonza Group AG | -- |
| Quanterix Corp. | -1.038 |
| Sartorius Stedim Biotech SA | 0.1111 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.24M |
| Revenue (Quarterly) | 166.82M |
| Total Expenses (Quarterly) | 221.06M |
| Enterprise Value | 569.38M |
| Gross Profit Margin (Quarterly) | -1.10% |
| Profit Margin (Quarterly) | -32.51% |
| Earnings Yield | -42.08% |
| Normalized Earnings Yield | -31.06 |